Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
Valerie McGuire(Cargill (Netherlands)), Brooke L. Fridley(Children's Mercy Hospital), Harvey A. Risch(University of New Haven), Elisa V. Bandera(Rutgers, The State University of New Jersey), Allan Jensen(Danish Cancer Society), Ellen L. Goode(Mayo Clinic in Arizona), Peter A. Fasching(Universitätsklinikum Erlangen), Sharon E. Johnatty(QIMR Berghofer Medical Research Institute), Claus Høgdall(Copenhagen University Hospital), Jenny Chang‐Claude(Universität Hamburg), Florian Heitz(Kliniken Essen-Mitte), Robert A. Vierkant(Mayo Clinic), Anna DeFazio(The University of Sydney), Estrid Høgdall(University of Copenhagen), Susanne K. Kjær(Copenhagen University Hospital), Marc T. Goodman(Cedars-Sinai Medical Center), Alice S. Whittemore(Cancer Registry of Norway), Andreas du Bois(Kliniken Essen-Mitte), Lene Lundvall(University of Copenhagen), Kathryn L. Terry(Brigham and Women's Hospital), Rachel Palmieri Weber(Duke University), Sián Fereday(Peter MacCallum Cancer Centre), Ignace Vergote(KU Leuven), Suzanne C. Dixon‐Suen(Cancer Council Victoria), Daniel W. Cramer(Brigham and Women's Hospital), Nicolas Wentzensen(National Cancer Institute), Joellen M. Schildkraut(Duke University Hospital), Keitaro Matsuo(Aichi Cancer Center), Louise A. Brinton(National Cancer Institute), Christina M. Nagle(The University of Queensland), Lisa E. Paddock(Rutgers, The State University of New Jersey), Jennifer A. Doherty(Cancer Prevention Institute of California), Francesmary Modugno(University of Pittsburgh), Philipp Harter(Kliniken Essen-Mitte), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Satoyo Hosono(Aichi Cancer Center), Hannah Yang(Cancer Prevention Institute of California), Els Van Nieuwenhuysen, Ira Schwaab(Cancer Institute of New South Wales), Kristine G. Wicklund(German Cancer Research Center), Melissa C. Larson(Mayo Clinic), Mary Anne Rossing(Fred Hutch Cancer Center), Sandrina Lambrechts(Dartmouth College), Kirsten B. Moysich(Roswell Park Comprehensive Cancer Center), R. B. Ness(Roswell Park Comprehensive Cancer Center), Lorna Rodríguez-Rodríguez(Rutgers, The State University of New Jersey), Jillian A. Hung(Millennium Institute), Jolanta Lissowska, MW Beckmann(Universitäts Frauenklinik)
Cited by 160
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k